Permethrin is a synthetic pyrethrin derivative acts as a neurotoxin by depolarizing the nerve cell membrane. Permethrin disrupts the sodium channel current by which membrane repolarization is regulated resulting in fatal paralysis of the nerves in the exoskeletal respiratory muscles of susceptible arthropods, including lice and mite. Permethrin is sold under brand names NIx and Elimite to treat pediculosis, scabies and demodicidosis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2362985 |
|||
Target ID: CHEMBL2362984 |
|||
Target ID: CHEMBL2362985 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25390654 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | ELIMITE Approved UseELIMITE (permethrin) 5% Cream is indicated for the treatment of infestation with Sarcoptesscabiei (scabies). Launch Date1989 |
|||
Curative | NIX Approved UseTo treat head lice. Launch Date1990 |
|||
Curative | NIX Approved UseA synthetic pyrethrin derivative; like natural pyrethrins, acts as a neurotoxin by depolarizing the nerve cell membrane. Disrupts the sodium channel current by which membrane repolarization is regulated resulting in fatal paralysis of the nerves in the exoskeletal respiratory muscles of susceptible arthropods, including lice and mites. Launch Date1986 |
|||
Curative | NIX Approved UseA synthetic pyrethrin derivative; like natural pyrethrins, acts as a neurotoxin by depolarizing the nerve cell membrane. Disrupts the sodium channel current by which membrane repolarization is regulated resulting in fatal paralysis of the nerves in the exoskeletal respiratory muscles of susceptible arthropods, including lice and mites. Launch Date1986 |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
49.46 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1871768 |
460 mg/kg single, oral dose: 460 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
0.6 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/26302029 |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Gallus gallus domesticus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
253 ng/mL |
143 g single, oral dose: 143 g route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
615 ng/mL |
143 g single, oral dose: 143 g route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
868 ng/mL |
143 g single, oral dose: 143 g route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
159 mg × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1871768 |
46 mg/kg single, intravenous dose: 46 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
PERMETHRIN plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
965 mg × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1871768 |
460 mg/kg single, oral dose: 460 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
1.95 mg × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/26302029 |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Gallus gallus domesticus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
16.45 mg × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/26302029 |
10 mg/kg bw single, intravenous dose: 10 mg/kg bw route of administration: Intravenous experiment type: SINGLE co-administered: |
PERMETHRIN serum | Gallus gallus domesticus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
2.73 μg × h/mL |
143 g single, oral dose: 143 g route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
6.26 μg × h/mL |
143 g single, oral dose: 143 g route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
8.67 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1871768 |
46 mg/kg single, intravenous dose: 46 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
PERMETHRIN plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
12.37 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/1871768 |
460 mg/kg single, oral dose: 460 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN plasma | Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED |
|
5.54 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/26302029 |
10 mg/kg bw single, oral dose: 10 mg/kg bw route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Gallus gallus domesticus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
4.73 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/26302029 |
10 mg/kg bw single, intravenous dose: 10 mg/kg bw route of administration: Intravenous experiment type: SINGLE co-administered: |
PERMETHRIN serum | Gallus gallus domesticus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
5.08 h |
143 g single, oral dose: 143 g route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: UNKNOWN |
|
4.82 h |
143 g single, oral dose: 143 g route of administration: Oral experiment type: SINGLE co-administered: |
PERMETHRIN serum | Homo sapiens population: UNHEALTHY age: ADULT sex: MALE food status: UNKNOWN |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
10% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/31248885 |
PERMETHRIN plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
Doses
Dose | Population | Adverse events |
---|---|---|
1 % 1 times / day multiple, topical Recommended Dose: 1 %, 1 times / day Route: topical Route: multiple Dose: 1 %, 1 times / day Sources: |
unhealthy, adult Health Status: unhealthy Condition: pediculosis Age Group: adult Sex: unknown Sources: |
Other AEs: Skin and subcutaneous conditions NEC... |
5 % 1 times / day multiple, topical Recommended Dose: 5 %, 1 times / day Route: topical Route: multiple Dose: 5 %, 1 times / day Sources: |
unhealthy, adult Health Status: unhealthy Condition: scabies Age Group: adult Sex: unknown Sources: |
Other AEs: Dystonia... |
200 ug/kg 1 times / day multiple, oral Recommended Dose: 200 ug/kg, 1 times / day Route: oral Route: multiple Dose: 200 ug/kg, 1 times / day Sources: |
unhealthy, adult Health Status: unhealthy Condition: crusted scabies Age Group: adult Sex: unknown Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Skin and subcutaneous conditions NEC | 1 % 1 times / day multiple, topical Recommended Dose: 1 %, 1 times / day Route: topical Route: multiple Dose: 1 %, 1 times / day Sources: |
unhealthy, adult Health Status: unhealthy Condition: pediculosis Age Group: adult Sex: unknown Sources: |
|
Dystonia | 5 % 1 times / day multiple, topical Recommended Dose: 5 %, 1 times / day Route: topical Route: multiple Dose: 5 %, 1 times / day Sources: |
unhealthy, adult Health Status: unhealthy Condition: scabies Age Group: adult Sex: unknown Sources: |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
no | ||||
yes |
Drug as victim
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
likely | ||||
likely | ||||
likely | ||||
likely | ||||
likely | ||||
no | ||||
no | ||||
no | ||||
no | ||||
yes [Km 2.8 uM] | ||||
yes | ||||
yes | ||||
yes | ||||
yes | ||||
yes |
PubMed
Title | Date | PubMed |
---|---|---|
Radiosynthesis and metabolism in rats of the 1R isomers of the insecticide permethrin. | 1976 Mar-Apr |
|
Purification and preliminary characterization of permethrinase from a pyrethroid-transforming strain of Bacillus cereus. | 1993 Jul |
|
High performance liquid chromatographic determination of diazinon, permethrin, DEET (N, N-diethyl-m-toluamide), and their metabolites in rat plasma and urine. | 2001 Jun |
|
A solid phase extraction reversed-phase HPLC method for the simultaneous determination of methoprene, permethrin and selected metabolites in rat plasma and urine. | 2001 Nov |
|
Thermal decomposition and isomerization of cis-permethrin and beta-cypermethrin in the solid phase. | 2002 Feb |
|
Neonatal exposure of newborn mice to pyrethroid (permethrin) represses activity-dependent c-fos mRNA expression in cerebellum. | 2002 Jul |
|
[Inhibitory effect of zinc on beta-hexosaminidase release from RBL-2H3 cells by synthetic chemicals]. | 2004 Apr |
|
Determination of solid-liquid partition coefficients (K(d)) for diazinon, propetamphos and cis-permethrin: implications for sheep dip disposal. | 2004 Aug 15 |
|
Identification, expression, and purification of a pyrethroid-hydrolyzing carboxylesterase from mouse liver microsomes. | 2004 Jul 9 |
|
Effectiveness of residual spraying of peridomestic ecotopes with deltamethrin and permethrin on Triatoma infestans in rural western Argentina: a district-wide randomized trial. | 2004 Mar |
|
Separation and aquatic toxicity of enantiomers of synthetic pyrethroid insecticides. | 2005 |
|
Identification of amino acid residues in the insect sodium channel critical for pyrethroid binding. | 2005 Feb |
|
Enantioselectivity in environmental safety of current chiral insecticides. | 2005 Jan 18 |
|
Rapid analysis of pyrethroids in whole urine by high-performance liquid chromatography using a monolithic column and off-line preconcentration in a restricted access material cartridge. | 2005 May |
|
Lessons learned for the assessment of children's pesticide exposure: critical sampling and analytical issues for future studies. | 2005 Oct |
|
Purification and characterization of a novel pyrethroid hydrolase from Aspergillus niger ZD11. | 2005 Sep 21 |
|
Laboratory and scaled up evaluation of cis-permethrin applied as a new ultra low volume formulation against Aedes aegypti (Diptera: Culicidae). | 2006 Jan |
|
An intervention to reduce residential insecticide exposure during pregnancy among an inner-city cohort. | 2006 Nov |
|
Method of analysis of a selected group of pyrethroids in soil samples using off-line flow-through extraction and on-column direct large-volume injection in reversed phase high performance liquid chromatography. | 2006 Sep |
|
Permethrin may disrupt testosterone biosynthesis via mitochondrial membrane damage of Leydig cells in adult male mouse. | 2007 Aug |
|
Synergism between cis-permethrin and benzoyl phenyl urea insect growth regulators against Aedes aegypti larvae. | 2007 Mar |
|
Efficacy of permethrin cream and oral ivermectin in treatment of scabies. | 2007 Oct |
|
Pyrethroids: cytotoxicity and induction of CYP isoforms in human hepatocytes. | 2008 |
|
Multimedia measurements and activity patterns in an observational pilot study of nine young children. | 2008 Jan |
|
Pesticides and atopic and nonatopic asthma among farm women in the Agricultural Health Study. | 2008 Jan 1 |
|
Induction of hepatic estrogen-responsive gene transcription by permethrin enantiomers in male adult zebrafish. | 2008 Jun 23 |
|
High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. | 2008 Mar |
|
Neurobehavioral toxicology of pyrethroid insecticides in adult animals: a critical review. | 2008 Mar-Apr |
|
Cross-induction of detoxification genes by environmental xenobiotics and insecticides in the mosquito Aedes aegypti: impact on larval tolerance to chemical insecticides. | 2008 May |
|
The effect of insecticide synergists on the response of scabies mites to pyrethroid acaricides. | 2009 |
|
Ability of four emergent macrophytes to remediate permethrin in mesocosm experiments. | 2009 Aug |
|
Pyrethroid insecticides: isoform-dependent hydrolysis, induction of cytochrome P450 3A4 and evidence on the involvement of the pregnane X receptor. | 2009 May 15 |
|
Rhinitis associated with pesticide use among private pesticide applicators in the agricultural health study. | 2010 |
|
Estrogenic pyrethroid pesticides regulate expression of estrogen receptor transcripts in mouse Sertoli cells differently from 17beta-estradiol. | 2010 |
|
Estrogenic activities of two synthetic pyrethroids and their metabolites. | 2010 |
|
Time-dependent integrity during storage of natural surface water samples for the trace analysis of pharmaceutical products, feminizing hormones and pesticides. | 2010 Apr 19 |
|
Assessing hormone receptor activities of pyrethroid insecticides and their metabolites in reporter gene assays. | 2010 Jul |
|
Splice variant specific increase in Ca2+/calmodulin-dependent protein kinase 1-gamma mRNA expression in response to acute pyrethroid exposure. | 2010 May-Jun |
|
Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort. | 2010 Nov |
|
Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer. | 2010 Nov 15 |
|
A simple HPLC method for determination of permethrin residues in wine. | 2010 Oct |
|
Stereoselective biotransformation of permethrin to estrogenic metabolites in fish. | 2010 Oct 18 |
|
Fetal exposure to chlordane and permethrin mixtures in relation to inflammatory cytokines and birth outcomes. | 2011 Feb 15 |
|
Comparative study of human and mouse pregnane X receptor agonistic activity in 200 pesticides using in vitro reporter gene assays. | 2011 Feb 27 |
|
Permethrin treatment of head lice with knockdown resistance-like gene. | 2011 Jan 27 |
|
Antiplasmodial and antitrypanosomal activity of pyrethrins and pyrethroids. | 2011 Sep 14 |
|
The impact of early life permethrin exposure on development of neurodegeneration in adulthood. | 2012 Jan |
|
Permethrin exposure during puberty has the potential to enantioselectively induce reproductive toxicity in mice. | 2012 Jul |
|
Early life permethrin exposure induces long-term brain changes in Nurr1, NF-kB and Nrf-2. | 2013 Jun 17 |
|
Early life permethrin treatment leads to long-term cardiotoxicity. | 2013 Oct |
Patents
Sample Use Guides
Scabies: Thoroughly massage permethrin 5% cream into the skin from the head to the soles of the feet. Usually 30 grams is sufficient for an average adult. The cream should be removed by washing after 8 to 14 hours. Infants should be treated on the scalp, temple, and forehead. 1 application is generally curative. Lice: completely saturate the hair and scalp with the drug. Begin to apply it behind the ears and at the back of the neck. Leave the shampoo on the hair for 10 minutes, but no longer, rinse with warm water, towel dry hair and comb out tangles. If live lice are seen seven days or more after the first treatment, a second treatment should be given.
Route of Administration:
Topical
Substance Class |
Mixture
Created
by
admin
on
Edited
Sat Dec 16 19:22:38 GMT 2023
by
admin
on
Sat Dec 16 19:22:38 GMT 2023
|
Record UNII |
509F88P9SZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QP53AC04
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
||
|
WHO-ATC |
P03AC04
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
||
|
WHO-ATC |
P03AC54
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
13.5
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
ACTIVYL TICK PLUS (AUTHORIZED)
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
||
|
NCI_THESAURUS |
C29727
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
||
|
NDF-RT |
N0000175847
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
||
|
NDF-RT |
N0000006014
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
VECTRA 3D [AUTHORIZED]
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
||
|
EPA PESTICIDE CODE |
109701
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
509F88P9SZ
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
40326
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
permethrin
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
509F88P9SZ
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
760105
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
D026023
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
Permethrin
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
34911
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
100000091844
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
DTXSID8022292
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
4152
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
m8564
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | Merck Index | ||
|
C29354
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
5510
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
DB04930
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
PERMETHRIN
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
CHEMBL1525
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
U-105
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
6790
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
258-067-9
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
52645-53-1
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
SUB09734MIG
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | |||
|
33199
Created by
admin on Sat Dec 16 19:22:39 GMT 2023 , Edited by admin on Sat Dec 16 19:22:39 GMT 2023
|
PRIMARY | RxNorm |
All of the following components must be present:
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|